Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration

References

• Hu GL, Chun XL, Wang Y, et al. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment. Oncotarget. 2015;6:41258–41274.
   PubMed Web of Science ®Google Scholar
• Huang X, Liao W, Zhang G, et al. pH-sensitive micelles self-assembled from polymer brush (PAE-g-cholesterol)-b-PEG-b-(PAE-g-cholesterol) for anticancer drug delivery and controlled release. Int J Nanomed. 2017;12:2215–2226.
   PubMed Web of Science ®Google Scholar
• Durymanov MO, Rosenkranz AA, Sobolev AS, et al. Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics. 2015;5:1007–1020.
   PubMed Web of Science ®Google Scholar
• Sagnella SM, Duong H, MacMillan A, et al. Dextran-based doxorubicin nanocarriers with improved tumor penetration. Biomacromolecules. 2014;15:262–275.
   PubMed Web of Science ®Google Scholar
• Cun X, Ruan R, Chen J, et al. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. Acta Biomater. 2016;31:186–196.
   PubMed Web of Science ®Google Scholar
• Cheng X, Wang X, Cao Z, et al. Folic acid-modified soy protein nanoparticles for enhanced targeting and inhibitory. Mater Sci Eng C. 2016;71:298–307.
   PubMed Web of Science ®Google Scholar
• Wong C, Stylianopoulos T, Cui J, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Nat Acad Sci. 2011;108:2426–2431.
   PubMed Web of Science ®Google Scholar
• Wei HT, Sun Y, Li GH, et al. Preliminary pharmacokinetics of PEGylated oxaliplatin polylactic acid nanoparticles in rabbits and tumor-bearing mice. Artif Cells Nanomed Biotechnol. 2015;43:258–262.
   PubMed Web of Science ®Google Scholar
• Zha Q, Wang X, Cheng X, et al. Acid-degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro. Mater Sci Eng C. 2017;78:246–257.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yan Y, Shen Q, et al. A colon targeted drug delivery system based on alginate modificated graphene oxide for colorectal liver metastasis. Mater Sci Eng C. 2017;79:185–190.
   PubMed Web of Science ®Google Scholar
• Anirudhan TS, Anila MM, Franklin S, et al. Synthesis characterization and biological evaluation of alginate nanoparticle for the targeted delivery of curcumin. Mater Sci Eng C. 2017;78:1125–1134.
   PubMed Web of Science ®Google Scholar
• Chen B, Dai W, He B, et al. Current multistage drug delivery systems based on the tumor microenvironment. Theranostics. 2017;7:538–558.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653–664.
   PubMed Web of Science ®Google Scholar
• Sun Q, Ojha T, Kiessling F, et al. Enhancing tumor penetration of nanomedicines. Biomacromolecules. 2017;18:1449–1459.
   PubMed Web of Science ®Google Scholar
• Song X, Wan Z, Chen T, et al. Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment. Biomaterials. 2016;108:44–56.
   PubMed Web of Science ®Google Scholar
• Kandela I, Chou J, Chow K, et al. Registered report: co-administration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. ELIFE. 2017;6:1–14.
   Google Scholar
• Hu G, Zhang H, Zhang L, et al. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment. Int J Pharmaceut. 2015;496:1057–1068.
   PubMed Web of Science ®Google Scholar
• Ruan S, Cao X, Cun X, et al. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Biomaterials. 2015;8:100–110.
   Web of Science ®Google Scholar
• Luo C, Zhao J, Tu M, et al. Hyaluronan microgel as a potential carrier for protein sustained delivery by tailoring the crosslink network. Mater Sci Eng C. 2014;36:301–308.
   PubMed Web of Science ®Google Scholar
• Yan G, Chen Q, Xu L, et al. Preparation and evaluation of liver-targeting micelles loaded with oxaliplatin. Artif Cells Nanomed Biotechnol. 2016;44:491–496.
   PubMed Web of Science ®Google Scholar
• Yang S, Gao HL. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res. 2017;126:97–108.
   PubMed Web of Science ®Google Scholar
• Gao HL. Shaping tumor microenvironment for improving nanoparticle delivery. Curr Drug Metab. 2016;17:731–736.
   PubMed Web of Science ®Google Scholar
• Xiao W, Ruan S, Yu W, et al. Normalizing tumor vessels to increase the enzyme-induced retention and targeting of gold nanoparticle for breast cancer imaging and treatment. Mol Pharm. 2017;14:3489–3498.
   PubMed Web of Science ®Google Scholar
• Mao C, Xie X, Liu X, et al. The controlled drug release by pH-sensitive molecularly imprinted nanospheres for enhanced antibacterial activity. Mater Sci Eng C. 2017;77:84–91.
   PubMed Web of Science ®Google Scholar
• Glasgow MD, Chougule MB. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J Biomed Nanotechnol. 2015;11:1859–1898.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Huang Y, Zheng H. The effect of guanidinylation of PEGylated poly(2-aminoethyl methacrylate) on the systemic delivery of siRNA. Biomaterials. 2013;34:3120–3131.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mei L, Xu C, et al. Dual receptor recognizing cell penetrating peptide for selective targeting, efficient intratumoral diffusion and synthesized anti-glioma therapy. Theranostics. 2016;12:177–191.
   Web of Science ®Google Scholar
• Hu C, Cun XL, Ruan S, et al. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy. Biomaterials. 2018;168:64–75.
   PubMed Web of Science ®Google Scholar
• Ruan S, Hu C, Tang X, et al. Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation. ACS Nano. 2016;10:10086–10098.
   PubMed Web of Science ®Google Scholar
• Liu R, Xiao W, Hu C, et al. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis. J Control Release. 2018;278:127–139.
   PubMed Web of Science ®Google Scholar
• Ruan S, He Q, Gao HL. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. Nanoscale. 2015;7:9487–9496.
   PubMed Web of Science ®Google Scholar
• Zhou H, Fan Z, Deng J, et al. Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy. Nano Lett. 2016;16:3268–3277.
   PubMed Web of Science ®Google Scholar
• Gong H, Chao Y, Xiang J, et al. Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy. Nano Lett. 2016;16:2512–2521.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Wong C, Bawendi MG, et al. Multistage nanoparticles for improved delivery into tumor tissue. Meth Enzymol. 2012;508:109–130.
   PubMed Web of Science ®Google Scholar
• Miao L, Huang L. Exploring the tumor microenvironment with nanoparticles. Cancer Treat Res. 2015;166:193–226.
   PubMedGoogle Scholar
• Liu D, Choi S, Chen B, et al. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem. 2004;116:1178–1182.
   Google Scholar
• Kuroda K, DeGrado W, et al. Amphiphilic polymethacrylate derivatives as antimicrobial agents. J Am Chem Soc. 2005;127:4128–4129.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu Y, Wang C, et al. pH-sensitive nanomicelles for high-efficiency siRNA delivery in vitro and in vivo: an insight into the design of polycations with robust cytosolic release. Nano Lett. 2016;16:6916–6923.
   PubMed Web of Science ®Google Scholar
• Yildirim T, Traeger A, Sungur P, et al. Polymersomes with endosomal pH-induced vesicle-to-micelle morphology transition and a potential application for controlled doxorubicin delivery. Biomacromolecules. 2017;18:3280–3290.
   PubMed Web of Science ®Google Scholar
• Yu M, Han SC, Kou ZG, et al. Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance. Artif Cells Nanomed Biotechnol. 2018;46:323–332.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32:693–710.
   PubMed Web of Science ®Google Scholar
• Sukamporn P, Baek SJ, Gritsanapan W, et al. Self-assembled nanomicelles of damnacanthal-loaded amphiphilic modified chitosan: Preparation, characterization and cytotoxicity study. Mater Sci Eng C. 2017;77:1068–1077.
   PubMed Web of Science ®Google Scholar
• Huh KM, Kang HC, Lee YJ, et al. pH-sensitive polymers for drug delivery. Macromol Res. 2012;20:224–233.
   Web of Science ®Google Scholar
• Cun X, Chen J, Ruan S, et al. A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration. ACS Appl Mater Interfaces. 2015;7:27458–27466.
   PubMed Web of Science ®Google Scholar